首页 › 基金 › Opaleye Management Inc. › QTTB

Opaleye Management Inc. 对 QTTB 的持仓历史

Q32 Bio Inc · 医疗保健

Opaleye Management Inc. 在 Q2 2026 的 13F 申报中披露持有 QTTB(Q32 Bio Inc)931,000 股,市值约 US$11.9M,约占其申报组合的 1.07%,在其申报持仓中市值排名第 27 位。 Opaleye Management Inc. 最近 3 个申报季度中有 3 个季度披露了 QTTB 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)931.00K 股
申报持仓市值$11.86M
组合权重1.07%
首次申报Q4 2025
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Opaleye Management Inc. 对 QTTB 的持仓演变

Opaleye Management Inc. 于 Q4 2025 首次披露 QTTB 持仓:213,363 股(约 US$708K)。 该持仓在 Q2 2026 达到峰值 931,000 股,市值约 US$11.9M。 在 3 次申报中,Opaleye Management Inc. 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 931,000 股、市值约 US$11.9M,环比减持 -325,228 股。。 持仓曾出现大幅变动:Q1 2026 增持约 489% (随后一个季度股价上涨 98%)、Q2 2026 减持约 26% (随后一个季度股价下跌 35%)。

逐季持仓明细

季度股数金额变化
Q4 2025 213.36K $708.37K 新进
Q1 2026 1.26M $8.06M 增持
Q2 2026 931.00K $11.86M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 QTTB 与 13F 数据

QTTB(Q32 Bio Inc)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 QTTB,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 QTTB 的基金

查看 QTTB 的全部基金持有人 →

常见问题

How long has Opaleye Management Inc. held QTTB?

Opaleye Management Inc. has disclosed QTTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Opaleye Management Inc.'s current position in QTTB?

As of Q2 2026, Opaleye Management Inc. holds 931.00K shares of QTTB (Q32 Bio Inc), valued at $11.86M, representing 1.07% of its reported portfolio and ranking #27.

Has Opaleye Management Inc. been buying or selling QTTB?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. reduced its position in QTTB. The position peaked in Q2 2026 at 931.00K shares.

Which other funds hold QTTB?

Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.